Analysis of the Acute Mesenteric Ischemia in a Single Institution Over 10 Years
Launched by HOSPITAL DEL MAR · Mar 7, 2024
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on studying a serious condition called Acute Mesenteric Ischemia (AMI), which happens when the blood flow to the intestines is reduced, leading to potential health risks and a high chance of death if not treated quickly. The researchers at Hospital de Mar want to analyze how patients with AMI have been treated over the past 10 years to improve understanding and management of this condition.
To participate in this study, individuals must be diagnosed with Acute Mesenteric Ischemia and fall within the age range of 65 to 74 years old. However, people with certain other conditions, such as Chronic Mesenteric Ischemia or bowel obstructions, will not be eligible for this trial. Those who choose to participate can expect to contribute valuable information that could help improve future treatments for AMI. It's important to note that this trial is not yet recruiting participants, so there will be no immediate action needed from potential volunteers at this time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Acute Mesenteric Ischemia
- Exclusion Criteria:
- • Chronic Mesenteric Ischemia
- • Ischemic Colitis
- • Bowel obstruction strangulation
- • Inflamatory bowel necrosis
About Hospital Del Mar
Hospital del Mar is a leading healthcare institution located in Barcelona, Spain, renowned for its commitment to medical excellence and patient care. As a prominent clinical trial sponsor, Hospital del Mar actively engages in innovative research aimed at advancing medical knowledge and improving therapeutic outcomes across various specialties. The hospital boasts a multidisciplinary team of experienced researchers and healthcare professionals dedicated to conducting rigorous clinical trials in accordance with the highest ethical and regulatory standards. Through collaboration with academic institutions and industry partners, Hospital del Mar strives to translate research findings into tangible benefits for patients, enhancing the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported